INTRODUCTION
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tive method for the targeted gastrointestinal tract delivery of probiotics (Anal and Harjinder, 2007; Borgogna et al., 2010; Gerez et al., 2012; Abd-Talib et al., 2013; SernaCock and Vallejo-Castillo, 2013) . However, industrialscale probiotic microencapsulation (Burgain et al., 2011) remains challenging because of the low production capacity and large particle sizes (Krasaekoopt et al., 2003) .
Emulsion and internal gelation is a method for encapsulating living cells with hydrocolloids (alginate, pectin, and carrageenan) on the basis of the relationship between discontinuous (cell-polymer suspension) and continuous (oil) phases. This method is easy to scale up, has a high bacterial survival rate (Chen and Chen, 2007) , and enables the production of targeted microcapsule sizes by varying the water-to-oil ratio and agitation speed (Kailasapathy, 2009) . Saccharomyces boulardii is a nonpathogenic yeast widely used as a probiotic in humans and animals (Lourens-Hattingh and Viljoen, 2001 ). The oral administration of S. boulardii improves intestinal health, induces innate immunity, and interacts with resident microflora at the mucosal interface (Kotowska et al., 2005) . Here, we evaluated the production of microencapsulated S. boulardii in a 500-L fermenter using emulsion and internal gelation and the effects of the products on the growth performance, antioxidant activity, immune function, and cecal microbiota in broilers.
MATERIALS AND METHODS
The study was approved by the Northeast Agricultural University (Harbin, China) and was performed in accordance with the Guidelines for Experimental Animals of the Animal Welfare Committee.
Bacterial Strains
The S. boulardii used in this study was obtained from the China General Microbiological Culture Collection Center (number 10381) and cultured as free (unencapsulated) or microencapsulated cells in yeast peptone dextrose broth at 30°C under aerobic conditions for 14 h.
Pilot-Scale Preparation of Saccharomyces boulardii Microcapsules
Sodium alginate with over 99% purity was purchased from the Sinopharm Chemical Reagent Corporation (Beijing, China). The viscosity of sodium alginate was over 20 cP when dissolved to form a 1% (wt/vol) aqueous solution at 20°C, and the guluronate/mannuronate rate was 1.46. Pilot-scale microencapsulation of probiotics was performed by emulsion and internal gelation as modified by Krasaekoopt et al. (2003) . Saccharomyces boulardii was proliferated in a 50-L fermenter, and then 800 g of sodium alginate and concentrated probiotic bacteria (10 8 cfu/mL) were added and mixed with 200 g of calcium carbonate dissolved in 33 L of sterile water (Fig. 1) . After homogenization, the mixture was dispersed into a 500-L fermenter containing 0.2% (wt/ vol) Span-80 (Sinopharm Chemical Reagent Corporation, Beijing, China) and emulsified for 5 min by stirring at 85 rpm. Then, 400 mL of glacial acetic acid mixed with 160 L of paraffin oil were added and stirred for 10 min. Sterilized water was added to the emulsification system, such that the microbeads could be loaded with bacteria into the water phase while the top oil layer was collected by aspiration and centrifuged for subsequent use. After washing 3 times with sterile water, fresh yeast peptone dextrose medium was added to the fermenter for the continuous growth of microencapsulated bacteria. Finally, the proliferated microencapsulated probiotics with a final cell density of about 1.0 × 10 11 cfu/g were collected and dried in a fluidized bed. Microcapsules were broken with chemical treatment as described by Qi et al. (2006) and were transferred to yeast peptone dextrose agar plates to determine the number of S. boulardii cells. The free cultured bacteria were collected, dried in a fluidized bed, and used as a control.
Measurement of Microcapsule Diameter
Before and after the culture, microcapsules (30 g) were dispersed in water, and a Mastersizer-2000 Laser Particle Analyzer (Malvern Instruments Ltd., Malvern, UK) was used to measure their diameter. Particle diameter distribution was reported using the volume moment mean of the particle (D[4,3] ). Analysis of all samples was performed in triplicate.
Feeding Experiment
A total of seven hundred 1-d-old male Arbor Acres broilers with an initial BW of 45 ± 0.5 g were obtained from a local commercial hatchery (Yinong Poultry Ltd., Tongliang, China). All broilers were raised in stainless steel pens (1.75 × 1.55 m) placed in a controlled-environment room under continuous light. The room temperature was maintained at 35°C for the first 3 d and then reduced to 24°C until the end of the experiment. Broilers were randomly allotted into 7 dietary treatments. Each group included 5 replicate pens with 20 broilers per pen. Broilers had access to feed and water ad libitum throughout the experiment. The basal diet was formulated to meet the nutritional requirements of broilers as suggested by the NRC (1994; Table 1 ). The dietary treatments used in this study were as follows: 1) basal diet (CON), 2) basal diet containing 0.1% Aureomycin (ANT; Agrichina company, Beijing, China), 3) basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed (P1), 4) basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed (P2), 5) basal diet containing 0.01% empty microcapsules (CAP), 6) basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed (CAPP1), and 7) basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed (CAPP2). Table 2 presents the content of CP, crude fat, crude fiber, lysine, methionine, calcium, and total phosphorus in each dietary treatment. The nutritional composition of each treatment was measured in 6 replicates. According to the China national standard methods (GB/T), the contents of CP and crude fat were measured using the Kjeldahl and Soxhlet extraction methods, respectively; crude fiber was measured by the acid alkali method. Lysine and methionine were detected by an automatic amino acid analyzer; calcium and total phosphorus were determined by complexometric titration and spectrophotometric methods, respectively. The feeding experiment was divided into 2 phases: the starter phase from d 1 to 21 and the grower phase from d 22 to 42. Body weight was recorded per pen on a weekly basis from d 1 to 42. In addition, the feed intake between weigh-ins was determined in each pen by measuring feed residue on the weigh-in days as the birds were weighed. The gain-to-feed ratio (F:G) that represents the proportion of feed that is converted into BW gain was calculated as the weight of feed intake divided by the BW gain per pen.
Blood Characteristics and Immune Organ Indices
A total of 15 broilers (3 birds from each replicate pen) were randomly selected from each treatment and bled via the wing vein on d 21 and 42. Blood samples (10 mL) were collected into 10-mL silica vacutainer tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ), stored on ice during collection, and immediately centrifuged (15 min at 1,610 ×g at 4°C) to separate the serum. Sera were carefully separated and stored in vacutainer tubes at −20°C (Ahmed et al., 2014) . All carcasses were opened to collect spleen and bursa of Fabricius and to calculate the immune organ indices as immune organ weight × 1,000 BW (Chen et al., 2003) . Reagent kits for IgG, IgM, IgA, cluster of differentiation 3, cluster of differentiation 4, cluster of differentiation 8, malondialdehyde, total superoxide dismutase, and catalase were obtained from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Serum IgG, IgM, IgA, and cluster of differentiation 3, cluster of differentiation 4, and cluster of differentiation 8 were determined by double-antibody sandwich ELI-SA (Frydecka et al., 1995; Yang et al., 2012) . Malondialdehyde level was measured as 2-thiobarbituric acid reactive substances; total superoxide dismutase activity was measured using the xanthine oxidase method, and catalase activity was detected with visible spectroscopy.
Cecal Microflora
Cecal content samples were analyzed on d 21 and 42. Forty-two samples were collected into sterile containers, packed carefully, frozen by immersion in liquid N 2 , and stored at −80°C (Eren et al., 2015) . The cecal microbiota was analyzed using high-throughput sequencing that included DNA extraction, PCR amplification of 16S rRNA, amplicon sequencing, and sequence data processing. Microbial genomic DNA was extracted from cecal contents using a Power Soil DNA Isolation Kit (Mo Bio, Carlsbad, CA) following the manufacture's protocol. The V3 hypervariable region of 16S rRNA was amplified by PCR from microbial genomic DNA using the following barcoded fusion primers: 338-CCTACGGGA GGCAGCAG-355 with adaptor A (forward) and 502-ATTACCGCGGCTGCTGG-518 with adaptor B (reverse). PCR conditions were 94°C for 5 min followed by 25 cycles of 94°C for 30 s, 48°C for 30 s, and 72°C for 30 s, with a final extension step of 72°C for 10 min. The PCR products were excised from 2% agarose gels and purified with MinElute Gel Extraction Kit (Qiagen, Venlo, Limburg, The Netherlands). The final sequencing library was prepared by mixing equal amounts of purified PCR products, ends were repaired, and poly(A) was added. The amplicons were then connected with sequencing adapters. After agarose gel electrophoresis, suitable fragments were selected as templates for PCR amplification. Finally, the library was sequenced using Illumina MiSeq (Beijing Centre for Physical and Chemical Analysis, Beijing, China). After sequencing, all barcodes were sorted and removed, and the quality of reads was assessed. To reduce the incidence of random sequencing errors, sequences shorter than 100 bp, with mismatches in PCR primers, or with more than 1 undetermined nucleotide and an average Phred quality of ≤25 were eliminated (Zhao et al., 2013) . Barcodes and primers were trimmed from the assembled sequences, and trimmed sequences were uploaded to Mothur (http://www.mothur.org) and QIIME (http://qiime.org) for further analysis. A detailed diagram of the analysis process is shown in Fig. 2 .
Data Analysis
Analysis of variance in conjunction with Tukey's post hoc test and principal component analysis were performed using SPSS for Windows (version 17.0; IBM, Chicago, IL). Means were considered statistically significant at P < 0.05. Figure 3A shows the size and shape of typical beads that were freshly prepared in the fermenter at an emulsification agitation rate of 500 rpm. These beads were highly spherical over the entire range of agitation rate and loaded with S. boulardii. The microcapsules were loaded with microbial cells after 12 h of incubation (Fig. 3B) .
RESULTS

Performance of Microencapsulation
The diameter of freshly prepared beads (549 μm on average) followed a normal distribution (Fig. 3C ). After incubation, the microcapsules expanded slightly and reached an average diameter of 631 μm (Fig.  3C ). The breakage of microbeads was not significant during the process. After drying, microcapsules were white, uniform, and spherical (Fig. 3D) . The weight of final wet microcapsules loaded with bacteria was 20.73 ± 4.05 kg, whereas the weight of dry products was 15.12 ± 1.96 kg (Fig. 3E) . 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
2 Each mean represents 5 replicate pens with 20 broilers per pen. 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
2 Each mean represents 5 replicate pens with 3 broilers per pen.
Growth Performance of Broilers
The growth performance of broilers in each dietary treatment and feeding phase is presented in Table 3 . In the starter phase (d 1 to 21), the ADG of broilers in CAPP1 was significantly (P < 0.05) greater than that in CON and CAP, but the G:F were not significantly different. In both feeding phases (starter and grower), the ADG of broilers in CAPP1 was significantly (P < 0.05) greater than that in CON or CAP. The G:F:G in CAPP1 was significantly (P < 0.05) lower than that in CON and CAP.
Immune Organ Indices
In the starter phase, the bursa index in CAPP2 was significantly (P < 0.05) greater than that in CAP, whereas in the grower phase, the bursa index in CAPP1 was significantly (P < 0.05) greater than that in ANT. The spleen indices did not differ significantly among treatments in either feeding phase (Table 4 ).
Blood Characteristics
Serum antioxidant indices in each dietary treatment and feeding phase are presented in Table 5 . Catalase activities in CAPP1 and CAPP2 were greater than those in other treatments in both feeding phases and significantly (P < 0.05) greater in CAPP2 than that in CON. In the grower phase, total superoxide dismutase activities in ANT and CAPP2 were significantly (P < 0.05) greater than those in CON. Malondialdehyde levels did not differ significantly among treatments in either feeding phase. 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
2 Each mean represents 5 replicate pens with 3 broilers per pen. 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
Serum immunoglobulin concentrations in each treatment and feeding phase are presented in Table 6 . In the starter phase, serum IgG concentration in CAPP2 was the greatest among treatments and was significantly (P < 0.05) greater than that in CON. In the grower phase, IgM concentration in CAPP1 was significantly (P < 0.05) greater than that in CON and CAP. In both feeding phases, serum IgG concentration was the greatest in CAPP2 and was significantly (P < 0.05) greater than that in CON in the starter phase and CAP in the grower phase. Serum IgA concentration did not differ significantly among treatments in either feeding phase.
Serum cellular immunity in each treatment and feeding phase is presented in Table 7 . In the starter phase, cluster of differentiation 3 concentrations in CAPP1 and CAPP2 were significantly (P < 0.05) greater than those in the other groups with the exception of P2 and P1. Cluster of differentiation 3 concentrations in CAPP1 and CAPP2 were significantly (P < 0.05) greater than those in CON and CAP in the grower phase. Cluster of differentiation 4 concentration in CAPP1 was the greatest among treatments and was significantly (P < 0.05) greater than those of CON and ANT in the starter phase and CON and CAP in the grower phase. Cluster of differentiation 8 concentration and cluster of differentiation 4/cluster of differentiation 8 did not differ significantly among treatments in either feeding phase.
Cecal Microflora
A total of 1,378,979 V3 16S rRNA amplicon sequence reads were analyzed from 21 samples collected on d 21. The maximum number of sequences per sample was 323,986, and the minimum was 13,794. Sample richness and diversity expressed in terms of the number of operational taxonomic units and the Shannon, Chao1, and Simpson indices did not differ significantly among treatments on d 21 (data not shown). A total of 1,390,884 V3 16S rRNA sequence reads were analyzed from 21 samples collected on d 42. The maximum number of reads per sample was 329,895, and the minimum was 14,150. CAPP1 had the greatest Chao1 index and number of operational taxonomic units among treatments. The Shannon and Simpson indices were greater in CAPP1 and CAPP2 than in CON or CAP (Table 8) .
Taxon abundance per sample was analyzed at the phylum, class, order, family, and genus levels using the Ribosomal Database Project with a bootstrap confidence threshold of 80%. The phylum Firmicutes was the dominant one in both feeding phases, comprising 40%-84% of the samples in the starter period and 80% to 95% in the grower period. On d 21, the number of Firmicutes was significantly (P < 0.05) depleted in CAPP1 compared with CON and CAP, whereas the number of Bacteroidetes was significantly (P < 0.01) enriched in ANT (Table 9 ).
The number of Bacteroides was significantly (P < 0.05) enriched in ANT on d 21 (Table 10) , whereas the number of Lactobacillus and Fecalibacterium was significantly (P < 0.05) enriched in CAPP1 on d 42 (Table 10 ). The 3-dimensional principal component analysis plot showed the clear effect of microcapsule treatment since the distance between CAPP2 and P2 on d 42 was the longest (Fig. 4) . 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
DISCUSSION
The use of microcapsules for protecting probiotic cells is increasingly important to the feed, food, and medical industries. However, microencapsulation remains challenging because of the complexity of the preparation process that currently limits large-scale production. Emulsion and internal gelation is a relatively new method that has been considered easy to scale up for mass production (Rokka and Pirjo, 2010) . To evaluate the pilot-scale production of microencapsulated S. boulardii by emulsion and gelation, a 500-L fermenter was used in this study. Microcapsules loaded with S. boulardii were incubated in the fermenter, and the bacterial cells grew for 12 h. The results showed that cell survival was not significantly affected by suspension in alginate under CaCO 3 conditions. Qi et al. (2006) suggested that the most suitable diameter of microcapsules for microbial microencapsulation is 500 to 600 μm. In this study, the diameter of freshly prepared beads followed a normal distribution and was 549 μm on average. The bacterial cells multiplied well without any significant breakage, indicating that the bacterial diameter could be controlled by adjusting the agitation rate.
A previous study showed that microcapsule coating with an additional film of compounds, such as polylysine or chitosan, offers increased protection against the host immune system (Burgain et al., 2011) . Coating is a promising method for reducing the cost and complexity of microencapsulation for products used in the food and feed industry. Although membrane formation was not tested in this study, bacteria grew well. 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
2 Each treatment was measured in triplicate.
Dry microcapsule powder is usually needed for transport and storage. Spray-drying, freeze-drying, and fluid-bed drying are typical processes used to dehydrate microbial cells (Szafran et al., 2012; Ezhilarasi et al., 2013; Du et al., 2014) . We used fluid-bed drying that produced microcapsules with a uniform, spherical appearance. Spray-drying was considered impractical because the water content of microcapsules was approximately 25%, and microcapsules adhered to each other when separated from the medium. Freeze-drying was excluded because of its high cost and low efficiency.
To assess the effects of microencapsulated probiotics compared with unencapsulated probiotics and empty microcapsules, a feeding study was performed. Microencapsulated S. boulardii supplementation of broilers improved their growth performance, immune indices, cellular immunity, antioxidant activity, and serum immunoglobulin concentrations. Except for the functional benefits of S. boulardii for broilers, the results also showed the protection of probiotics by microencapsulation. Additionally, the lack of significant differences between birds fed the basal diet and empty microcapsules treatments indicated that the materials used for the preparation of microcapsules had no effect on broilers.
The gastrointestinal tract is the essential sensory organ of the immune response, nutrient absorption, and pathogen defense (Yan and Polk, 2010; Correia et al., 2012) . The intestinal microbiota can be considered an additional organ that plays an important role in modulat- 1 CON, basal diet; ANT, basal diet containing 0.1% Aureomycin; P1, basal diet containing unencapsulated Saccharomyces boulardii at a dose of 1 × 10 8 cfu/kg of feed; P2, basal diet containing unencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed; CAP, basal diet containing 0.01% empty microcapsules; CAPP1, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 8 cfu/kg of feed; and CAPP2, basal diet containing microencapsulated S. boulardii at a dose of 1 × 10 10 cfu/kg of feed.
ing immunity and fortifying the mucosal barrier (RajilicStojanovic et al., 2007) . The microbial population in the broiler intestine is a dynamic and complex ecosystem consisting of more than 1,000 described species and approximately 10 10 to 10 11 cells/g of cecal contents (Gong et al., 2002) . Many studies have focused on the use of probiotics in poultry to combat and prevent digestive disorders by the competitive exclusion of intestinal pathogens (e.g., Escherichia coli, Salmonella sp., Clostridium perfringens), antimicrobial secretions (bacteriocins), and stimulation of an immune response to improve performance and productivity (Stern et al., 2006; Lessard et al., 2009) . In this study, we showed that the species composition of gut microbial communities varied and was influenced by both free and microencapsulated S. boulardii. The richness and diversity of intestinal microorganisms significantly improved with the addition of microencapsulated S. boulardii and also with broiler age, similar to results reported in previous studies (Danzeisen et al., 2011; Han et al., 2012) . Among all treatments, birds fed the low concentration of microencapsulated S. boulardii had the greatest number of Lactobacillus sp. that are known to play a key role in regulating BW and have a long use history as exogenous probiotics. Most exogenous microbial cells remain inactive in the low-pH environment of the stomach or the complex multienzyme conditions of the intestine (Iyer et al., 2004) . Our data showed that microencapsulation improves the viability of microorganisms in the gastrointestinal tract since several parameters in the microencapsulated S. boulardii treatments were improved compared with those in the unencapsulated treatments. These results are in agreement with those reported by Krasaekoopt et al. (2003) and Picot and Lacroix (2004) .
The use of antibiotics as growth promoters has been banned in many countries worldwide because of the increasing resistance of pathogens to antibiotics and the accumulation of antibiotic residues in animal products and the environment (Vandenbogaard and Stobberingh, 2000; Brufau et al., 2015) . Microencapsulated probiotics are a promising alternative to antibiotic growth promoters without any clinical side effects. Our results showed that the dietary administration of microencapsulated probiotics to broilers had results equal to or better than those of Aureomycin.
In conclusion, this study demonstrated the feasibility of probiotic cell microencapsulation in a 500-L fermenter using emulsion and internal gelation. Furthermore, the results showed that the dietary administration of microencapsulated S. boulardii to broilers effectively improved the composition of beneficial intestinal microbes, immune function, and growth performance.
LITERATURE CITED
